Gentamicin serum concentrations: pharmacokinetic predictions.
about
Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapyComputerized diagnosis: implications for clinical educationPharmacokinetics of amoxicillin: Dosage nomogram for patients with impaired renal function.Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function.Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.Estimation of pharmacokinetic parameters based on the patient-adjusted population data.Prospective comparative study of efficacy and toxicity of netilmicin and amikacinPlasma beta 2 microglobulin as a means of predicting gentamicin serum concentrations.Predictive performance of gentamicin dosing nomograms.Pharmacokinetic and pathological evaluation of gentamicin in cats given a small intravenous dose repeatedly for five days.A gentamicin order form improves its useComparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patientsEvaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin.Monitoring digoxin therapy: III. How useful are the nomograms?Changes in the apparent half life of gentamicin and tobramycin without detectable changes in creatinine clearance.Comparison of methods for estimating gentamicin clearance and retrospective analysis of changes in clearance with emphasis on patients with normal renal functionIncreased aminoglycoside dosage requirements in hematologic malignancy.Aminoglycoside therapy: current and prospective uses.Use of antibiotics in the elderlyGentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations.Adjusted body weight, con: why adjust body weight in energy-expenditure calculations?Netilmicin and gentamicin: comparative pharmacology in humans.Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary diseaseGentamicin: use of a programmable calculator to determine dosages from pharmacokinetic data for individual patients.Aminoglycoside pharmacokinetics: volume of distribution in specific adult patient subgroups.Evolution of Clinical Pharmacy in the USA and Future Directions for Patient CareAntimicrobial dosing considerations in obese adult patients.Once-daily aminoglycoside administration: new strategies for an old drug.The clinical pharmacist and research.Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients.Recurrent methicillin-resistant Staphylococcus aureus osteomyelitis: combination antibiotic therapy with evaluation by serum bactericidal titers.Intravenous streptomycin use in a patient infected with high-level, gentamicin-resistant Streptococcus faecalis.Drug therapy in the elderly: the clinical pharmacology of aging.Abnormal pharmacokinetics: the need for monitoring.Pharmacoeconomic evaluation of once-daily aminoglycoside treatment.Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacin.Aminoglycoside pharmacokinetics on a microcomputer.Gentamicin dosage schedules.Failure of a nomogram to achieve target aminoglycoside concentrations.
P2860
Q28379292-42239BF2-AB5C-4F93-A9F0-009543080758Q29709750-7B573926-199A-447D-814D-1FC045878EE7Q30450459-CCCD015D-D402-4449-8036-7B633AC3D5E4Q30450471-F1EB2B33-B8F6-44D1-80E5-82F9F1A4B5BCQ30451388-6A8331E6-FBAE-4E52-9324-878115861694Q31082856-25A4C5DD-B619-4DF0-BF36-5B2CE6AC03ACQ33723887-6CF1BED2-8663-4701-A564-4D08A003D21FQ33726319-431A1681-7712-46D4-A278-3353F4AE6E80Q34075284-F0676572-47B6-471E-8226-53DD62715179Q34080768-5C60C032-476B-4619-9D31-76ABA88EF3E7Q34188676-FB6DFA7A-56AB-4AE4-8FFE-8075168B5225Q34397816-93BFE448-BA12-40B0-8A18-E060C1192902Q34417050-4F02EAA2-E565-4B3F-8887-A2ECCF128243Q34516197-C3F504C5-22AB-4951-85B3-DB18BCFE861EQ34517605-E1CD9840-D21C-4964-BDF8-CDCF9A681070Q34620939-1F5F7832-6A8E-4FEE-BC00-B072EE41CE82Q35253342-FC1A100B-780C-4CC6-8346-1D36A71FB638Q35645042-A28C55D8-352B-498E-8E32-5E7A1D37AF78Q35650978-6AD6D544-9147-44D4-8E2F-71CFBF639437Q35674282-B36C8779-CD8D-49AF-9EDD-0A7BD4B2FADDQ36278432-F3AA8DE9-3369-4635-989C-D7224CDC77B6Q36461552-506C7E8E-8045-4C08-AE88-432C53B6633BQ36483889-4C029456-D27D-4BF0-BE34-BB5A90CEDC4FQ36656388-D8BDA28C-E69D-416B-88C5-36C05639AFFFQ36725610-9522000F-BD03-40EC-8924-6A2327E9AE50Q36767799-3DED0506-FAB9-400A-AFC9-A51239853610Q36892796-76E92013-6576-438C-A531-F5783A223B60Q38239743-C5B3FD9A-DA64-4420-9BC7-2DEE4DAE121EQ38577429-AA19A7B0-686F-43B4-A699-053923AECFD5Q39598341-495E76B7-044A-4E59-89AC-402AE2233B0EQ39829144-14FBC4CF-7732-4EA1-B6B1-9514F05641F7Q40682755-BF64DDD4-DB9B-4B2A-B8E4-7F3A5E613D03Q40824627-97FA618A-7235-47F8-8112-629CFF8B84DAQ40875061-DF75B58C-500D-41CE-B393-10D32A37C0A8Q40899086-0B160FFA-B416-4019-BBC7-0222B87A1887Q40949900-1DFAF2A2-6ED2-4C69-96FD-EF06519A4344Q42226724-25356B45-C218-4692-AE8B-0D909E3F0043Q42668043-384BE40E-E5A7-4D33-9CCE-F661FF7D583CQ42732986-C92A701C-B69A-4343-BA6C-050E2A64C9B0Q42908644-A9EA11CD-FBE2-46F2-BF15-9B4533B773A5
P2860
Gentamicin serum concentrations: pharmacokinetic predictions.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Gentamicin serum concentrations: pharmacokinetic predictions.
@en
Gentamicin serum concentrations: pharmacokinetic predictions.
@nl
type
label
Gentamicin serum concentrations: pharmacokinetic predictions.
@en
Gentamicin serum concentrations: pharmacokinetic predictions.
@nl
prefLabel
Gentamicin serum concentrations: pharmacokinetic predictions.
@en
Gentamicin serum concentrations: pharmacokinetic predictions.
@nl
P1476
Gentamicin serum concentrations: pharmacokinetic predictions.
@en
P2093
Sarubbi FA Jr
P304
P356
10.7326/0003-4819-85-2-183
P407
P577
1976-08-01T00:00:00Z